Upgrades/Downgrades
Updated: 15-Jun-26 16:30 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Silvercorp Metals | SVM | Roth Capital | Neutral » Buy | $13.75 | |
| Rocket Lab USA | RKLB | KeyBanc Capital Markets | Sector Weight » Overweight | $135 | |
| Paychex | PAYX | Citigroup | Neutral » Buy | $140 | |
| HawkEye 360 | HAWK | Jefferies | Hold » Buy | $34 | |
| Firefly Aerospace | FLY | KeyBanc Capital Markets | Sector Weight » Overweight | $50 | |
| Ferrari | RACE | Morgan Stanley | Equal-Weight » Overweight | $438 | |
| Datadog | DDOG | Truist | Hold » Buy | $300 | |
| Aviat Networks | AVNW | Northland Capital | Market Perform » Outperform | $25 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Traws Pharma | TRAW | Ladenburg Thalmann | Buy » Neutral | ||
| Saia | SAIA | Citigroup | Buy » Neutral | $524 | |
| Runway Growth Finance | RWAY | BofA Securities | Neutral » Underperform | $5.50 | |
| Roku | ROKU | Robert W. Baird | Outperform » Neutral | $160 | |
| Old Dominion | ODFL | Citigroup | Neutral » Sell | $228 | |
| Nu Holdings | NU | Citigroup | Buy » Neutral | $13 | |
| MGM Resorts | MGM | Stifel | Buy » Hold | $49 | |
| Knight-Swift | KNX | Citigroup | Buy » Neutral | $90 | |
| Intercorp Financial | IFS | JP Morgan | Overweight » Neutral | $56 | |
| Curbline Properties | CURB | Wolfe Research | Outperform » Peer Perform | ||
| Credicorp LTD | BAP | JP Morgan | Overweight » Neutral | $415 | |
| Cheesecake Factory | CAKE | Northcoast | Buy » Neutral | ||
| C.H. Robinson | CHRW | Citigroup | Buy » Neutral | $199 | |
| Caesars Entertainment | CZR | Stifel | Buy » Hold | $31 | |
| Accenture | ACN | Morgan Stanley | Overweight » Equal-Weight | $177 | |
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Braiin Limited | BRAI | Maxim Group | Buy | $10 | |
| Twist Bioscience | TWST | Canaccord Genuity | Buy | $90 | |
| TeraWulf | WULF | BofA Securities | Buy | $34 | |
| Onto Innovation | ONTO | Morgan Stanley | Overweight | $371 | |
| Lincoln International | LCLN | Wolfe Research | Outperform | $29 | |
| Lincoln International | LCLN | Citizens | Mkt Outperform | $30 | |
| Lincoln International | LCLN | Keefe Bruyette | Mkt Perform | $26 | |
| Lincoln International | LCLN | BMO Capital Markets | Market Perform | $26 | |
| Lincoln International | LCLN | Evercore ISI | In-line | $25 | |
| Lincoln International | LCLN | Morgan Stanley | Equal-Weight | $27 | |
| Lincoln International | LCLN | Goldman | Buy | $27.50 | |
| Kalaris Therapeutics | KLRS | TD Cowen | Buy | ||
| Jade Biosciences | JBIO | UBS | Buy | $45 | |
| ICU Medical | ICUI | BTIG Research | Buy | $170 | |
| Esco Tech | ESE | JP Morgan | Overweight | $420 | |
| EPAM Systems | EPAM | Wedbush | Neutral | $99 | |
| DuPont | DD | Goldman | Neutral | $53 | |
| Coupang | CPNG | CLSA | Outperform | $24 | |
| Ceva | CEVA | Needham | Buy | $55 | |
| Brookdale Senior Living | BKD | Compass Point | Buy | $22 | |
| Biodesix | BDSX | H.C. Wainwright | Buy | $26 | |
| Better Home & Finance | BETR | Roth Capital | Buy | $35 | |
| Ametek | AME | Citigroup | Neutral | $257 | |
| AIR Global | AIIR | Barclays | Overweight | $9 | |
| Kodiak AI | KDK | Craig Hallum | Buy | $12 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Citizens Financial Group | CFG | Stephens | Equal-Weight | ||
| Fifth Third | FITB | Stephens | Equal-Weight | ||
| Regions Fincl | RF | Stephens | Equal-Weight | ||
| Huntington Banc | HBAN | Stephens | Equal-Weight | ||
| U.S. Bancorp | USB | Stephens | Equal-Weight | ||
| KeyCorp | KEY | Stephens | Overweight | ||
| PNC | PNC | Stephens | Overweight | ||
| Zions Bancorp | ZION | Stephens | Overweight | ||
| Truist | TFC | Stephens | Overweight | ||
| 3M | MMM | Goldman | Buy | $190 | |
|
|
|||||
| Coverage Reiterated/Price Tgt Changed* | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Micron | MU | RBC Capital Mkts | Outperform | $525 » $1200 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |